CADM1 and cervical carcinoma: Methylation-mediated silencing of the CADM1 has been reported in cervical carcinoma cell line [7, 12], advanced stage of cervical intraepithelial neoplasia (CIN) lesion and cervical squamous cell carcinoma (SCC) lesion in hrHPV-positive women [7, 8].